PHARMACEUTICAL COMPOSITION AND THERAPEUTIC COMBINATION COMPRISING A CHOLESTERYL ESTER TRANSFER PROTEIN INHIBITOR AND HMG CoA REDUCTASE INHIBITORS

MA40590AUndetermined Publication Date: 2017-07-05DEZIMA PHARMA B V

View PDF 0 Cites 0 Cited by

Patent Information

Application Number: MA40590
Authority / Receiving Office: MA · MA
Patent Type: Applications
Current Assignee / Owner
Priority Date: 2014-08-28
Filing Date: 2015-08-03
Publication Date: 2017-07-05

Application Information

Patent Timeline

28 Aug 2014

Priority

03 Aug 2015

Application

MA40590

05 Jul 2017

Publication

MA40590A

IPC: A61K31/513; A61P9/00

CPC: A61K31/22; A61K31/366; A61K31/40; A61K31/405; A61K31/47; A61K31/4709; A61K31/505; A61K31/506

Inventors: JOHN Ford; KASTELEIN John

Get more patent work done with AI

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Patent Text Reader

Abstract

The present invention relates to a pharmaceutical composition and a therapeutic combination comprising a novel cholesteryl ester transfer protein (cetp) inhibitor and a hmg coa reductase inhibitor, which may be used in the treatment of subjects suffering

Need to check novelty before this filing date? Find Prior Art